Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics entities : Seres therapeutics, inc. save search
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -2.31%
H: 3.86%
C: -1.47%
ser-155 for trial therapeutics
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
Published: 2024-02-28 (Crawled : 13:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 0.0%
H: 7.89%
C: 0.88%
conference therapeutics financial results
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
Published: 2024-02-27 (Crawled : 14:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 0.0%
H: 8.41%
C: 6.54%
conference therapeutics
Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
Published: 2024-02-26 (Crawled : 17:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -0.94%
H: 3.81%
C: 1.9%
therapeutics financial
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 17, 2024
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -2.44%
H: 9.17%
C: 7.5%
nasdaq grants therapeutics
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 26.92%
H: 3.54%
C: -27.78%
ser-155 fda update designation commercial therapeutics
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
Published: 2023-12-08 (Crawled : 08:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 2.73%
H: 3.54%
C: -3.54%
ser-155 presentation therapeutics
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -2.59%
H: 2.65%
C: 0.0%
conference therapeutics
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
Published: 2023-11-21 (Crawled : 11:00) - prnewswire.com
OMGA | $2.42 -5.28% -5.58% 360K
|
|
| O: 0.0%
H: 2.99%
C: -4.5%
SANA | $7.74 -6.3% -6.72% 1.9M
|
|
| O: -2.09%
H: 0.48%
C: -4.75%
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 10.3%
H: 10.28%
C: -2.34%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -2.38%
H: 0.77%
C: 0.08%
FHTX | $5.58 -3.46% -3.58% 130K
|
Health Technology
|
| O: 0.0%
H: 4.14%
C: 0.0%
DNLI | $16.6 -1.31% -1.33% 1.2M
|
Health Technology
|
| O: -2.34%
H: 0.0%
C: -2.83%
frontier therapeutics
Seres Therapeutics to Highlight VOWST™ Data at IDWeek
Published: 2023-10-12 (Crawled : 12:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -1.18%
H: 0.6%
C: -11.68%
therapeutics
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)-October 6, 2023
Published: 2023-10-06 (Crawled : 13:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -2.15%
H: 0.49%
C: -4.63%
nasdaq grants therapeutics
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics
Published: 2023-10-02 (Crawled : 11:00) - prnewswire.com
OMGA | $2.42 -5.28% -5.58% 360K
|
|
| O: 4.65%
H: 0.0%
C: -16.0%
SANA | $7.74 -6.3% -6.72% 1.9M
|
|
| O: -0.26%
H: 0.0%
C: -7.25%
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -9.66%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.16%
H: 0.91%
C: 0.18%
FHTX | $5.58 -3.46% -3.58% 130K
|
Health Technology
|
| O: -1.0%
H: 0.83%
C: -10.3%
DNLI | $16.6 -1.31% -1.33% 1.2M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -3.6%
ceo therapeutics
ProFound Therapeutics Expands Leadership Team With Appointment of Klaus Urbahns as Chief Scientific Officer
Published: 2023-09-25 (Crawled : 13:00) - biospace.com/
OMGA | $2.42 -5.28% -5.58% 360K
|
|
| O: 0.32%
H: 0.95%
C: -4.76%
SANA | $7.74 -6.3% -6.72% 1.9M
|
|
| O: 3.92%
H: 2.01%
C: -1.26%
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 0.0%
H: 1.53%
C: -7.66%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.28%
C: -1.36%
FHTX | $5.58 -3.46% -3.58% 130K
|
Health Technology
|
| O: -1.16%
H: 3.68%
C: 2.51%
DNLI | $16.6 -1.31% -1.33% 1.2M
|
Health Technology
|
| O: -0.36%
H: 1.0%
C: -0.36%
therapeutics
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 8, 2023
Published: 2023-09-08 (Crawled : 18:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -0.93%
H: 2.02%
C: 0.62%
nasdaq grants therapeutics
Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-09-07 (Crawled : 14:30) - biospace.com/
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.12%
H: 0.0%
C: 0.0%
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -0.94%
H: 4.11%
C: 2.53%
conference global therapeutics
Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
Published: 2023-08-08 (Crawled : 13:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 4.34%
H: 8.52%
C: -10.81%
business therapeutics financial results
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 4, 2023
Published: 2023-08-04 (Crawled : 13:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 6.89%
H: 1.17%
C: -3.52%
nasdaq grants therapeutics
Seres Therapeutics to Host Second Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on August 8, 2023
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 0.0%
H: 2.49%
C: 0.42%
conference therapeutics financial results
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 14, 2023
Published: 2023-07-14 (Crawled : 23:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: -2.16%
nasdaq grants therapeutics
Seres Therapeutics to Present at Goldman Sachs Global Healthcare Conference
Published: 2023-06-09 (Crawled : 12:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 0.18%
H: 5.26%
C: 3.21%
conference global therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.